跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
JINARC tolvaptan 30 mg + 90 mg tablet blister composite pack - TGA Drug Approval Details
Approvals
/
TGA
/
JINARC tolvaptan 30 mg + 90 mg tablet blister composite pack
Approved
STANDARD
JINARC tolvaptan 30 mg + 90 mg tablet blister composite pack
Otsuka Australia Pharmaceutical Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 28, 2025
Approval ID
18f9ef5b59fddd4e
Company
Otsuka Australia Pharmaceutical Pty Ltd
Type
Standard
Approval Details
Approval Id
18f9ef5b59fddd4e
Product Name
JINARC tolvaptan 30 mg + 90 mg tablet blister composite pack
Artg Id
272789
Artg Name
JINARC tolvaptan 30 mg + 90 mg tablet blister composite pack
Sponsor
Otsuka Australia Pharmaceutical Pty Ltd
Company Detail Path
/organization/otsuka-australia-pharmaceutical-pty-ltd
Artg Date
2017-03-24
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/0a971f77cbc9038a94c893e3cdb4bd41.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/4fa73bea8f6f74b1ed8587eae6984f2f.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 28, 2025
Approval ID
18f9ef5b59fddd4e
Type
Standard
Back to TGA Approvals